Six years later, pharmaceutical trials still have the publication bias blues

May 6, 2015

Erick Turner, M.D. associate professor of psychiatry, OHSU School of Medicine, continues to take on pharmaceutical publication bias. His most recent research, published in JAMA Psychiatry and covered by Salon magazine, indicates little has changed in the way industry reports the findings of clinical trials.

Nearly every study (40 of 41) that the FDA determined to be positive ended up getting published. Of the studies the FDA determined weren't positive, almost half didn't get published; those that did were largely published in ways that conflicted with the FDA's findings.

"When the news is good, drug companies are going to see to it that the world knows about it and get the data published," Turner told me. "If the news is bad, the data is not quite as forthcoming." ReadDrug companies aren’t telling you the whole truth


An OHSU interview with Dr. Turner (2012) 

Bitter Pill (Willamette Week, 2008)